To identify SARS-CoV-2 peptides, we performed label-free liquid chromatography with tandem mass spectrometry (LC-MS/MS) analysis of EVs isolated by CD9 direct immunocapture at the peak of infection. This evidence concerns the gene CD9 and infection.